{"id":24017,"date":"2022-05-13T14:27:22","date_gmt":"2022-05-13T13:27:22","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=24017"},"modified":"2022-05-13T14:27:25","modified_gmt":"2022-05-13T13:27:25","slug":"online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/","title":{"rendered":"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM"},"content":{"rendered":"\n<p>This workshop is intended primarily for academic groups or small start-ups with limited practical experience in all stages of therapeutics product development. <\/p>\n\n\n\n<p>The focus will be on the early phases of product development for antibacterial and antifungal agents, starting after discovery phase when leads have been identified. <\/p>\n\n\n\n<p>Workshop attendees should be in the early stages of product development and should have an identified product, library or scaffold that they are interested in developing into a therapeutic treatment or should be supporting early product development activities through their organization.<\/p>\n\n\n\n<p><a href=\"https:\/\/web.cvent.com\/event\/1e0bf68b-8f8c-4bea-93f2-02f9a88efa4e\/summary\" target=\"_blank\" rel=\"noreferrer noopener\">Register <\/a>by June 22, 2022, 11:59 PM<\/p>\n\n\n\n<p>Contact<a href=\"https:\/\/web.cvent.com\/event\/1e0bf68b-8f8c-4bea-93f2-02f9a88efa4e\/summary\" target=\"_blank\" rel=\"noreferrer noopener\"> us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This workshop is intended primarily for academic groups or small start-ups with limited practical experience in all stages of therapeutics product development. The focus will be on the early phases of product development for antibacterial and antifungal agents, starting after discovery phase when leads have been identified. Workshop attendees should be in the early stages [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":24019,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[35],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-13T13:27:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-13T13:27:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"461\" \/>\n\t<meta property=\"og:image:height\" content=\"526\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM\",\"datePublished\":\"2022-05-13T13:27:22+00:00\",\"dateModified\":\"2022-05-13T13:27:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\"},\"wordCount\":110,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg\",\"articleSection\":[\"Ev\u00e8nements &amp; Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\",\"name\":\"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg\",\"datePublished\":\"2022-05-13T13:27:22+00:00\",\"dateModified\":\"2022-05-13T13:27:25+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg\",\"width\":461,\"height\":526,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ev\u00e8nements &amp; Colloques\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/","og_locale":"fr_FR","og_type":"article","og_title":"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2022-05-13T13:27:22+00:00","article_modified_time":"2022-05-13T13:27:25+00:00","og_image":[{"width":461,"height":526,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM","datePublished":"2022-05-13T13:27:22+00:00","dateModified":"2022-05-13T13:27:25+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/"},"wordCount":110,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg","articleSection":["Ev\u00e8nements &amp; Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/","name":"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg","datePublished":"2022-05-13T13:27:22+00:00","dateModified":"2022-05-13T13:27:25+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Crocus.jpg","width":461,"height":526,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/online-event-strategies-for-early-stage-programs-developing-novel-antibacterial-and-antifungal-drugs-june-22-2022-june-23-20221000-am-300-pm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Ev\u00e8nements &amp; Colloques","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/"},{"@type":"ListItem","position":4,"name":"Online event: Strategies for Early-Stage Programs Developing Novel Antibacterial and Antifungal Drugs, June 22, 2022 \u2013 June 23, 202210:00 AM-3:00 PM"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-10 21:02:28","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/24017"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=24017"}],"version-history":[{"count":4,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/24017\/revisions"}],"predecessor-version":[{"id":24029,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/24017\/revisions\/24029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/24019"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=24017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=24017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=24017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}